This is a firm fixed-price delivery order awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) on December 16, 2024. The contract, valued at $6,671.79, is for the delivery of Eliquis 5 mg tablets with a completion date of December 17, 2024. This award is part of the DLA's Troop Support Medical ECAT Generation V Program, a larger indefinite delivery contract valued at $999,999,999.00 that allows Dakota Drug, Inc. to provide a wide range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract has no set-aside designation, indicating that Dakota Drug, Inc. was able to compete for this award on an unrestricted basis.
Generated 3/17/25, 9:53 AM